Incyte (INCY) Tax Rate (QoQ) (2010 - 2026)

Incyte (INCY) Tax Rate (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,184.45 Bn 68,184.17 Bn -
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 474.39 Bn 469.59 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.45 Bn 116.21 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.92 Bn 61.16 Bn 3.31 Bn
7 Belite Bio 63.43 Bn 63.43 Bn -
8 Argenx Se 56.67 Bn 51.49 Bn 1.41 Bn
9 Revolution Medicines 38.08 Bn 38.08 Bn -
10 Incyte 23.97 Bn 19.95 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,153.00
Dec 31, 2025 1,120.00
Sep 30, 2025 -1,537.00
Jun 30, 2025 -503.00
Mar 31, 2025 -342.00
Dec 31, 2024 388.00
Sep 30, 2024 4,605.00
Jun 30, 2024 -4,227.00
Mar 31, 2024 242.00
Dec 31, 2023 -96.00
Sep 30, 2023 7.00
Jun 30, 2023 -3,147.00
Mar 31, 2023 -655.00
Dec 31, 2022 4,059.00
Sep 30, 2022 -552.00
Jun 30, 2022 -1,652.00
Mar 31, 2022 41,594.00
Dec 31, 2021 -38,304.00
Sep 30, 2021 32.00
Jun 30, 2021 -987.00